Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1802]
News [2707]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
New MEK inhibitor, trametinib, improves survival in advanced melanoma
Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France
New MEK inhibitor, trametinib, improves survival in advanced melanoma ( Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France )
4 Jun 2012
First effective treatment for chemotherapy-induced peripheral neuropathy
Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA
First effective treatment for chemotherapy-induced peripheral neuropathy ( Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA )
4 Jun 2012
Afatinib delays progression of advanced lung adenocarcinomas
Dr James Yang - National Taiwan University Hospital, Taipei
Afatinib delays progression of advanced lung adenocarcinomas ( Dr James Yang - National Taiwan University Hospital, Taipei )
4 Jun 2012
EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2...
Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA
EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2-positive breast cancer ( Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA )
3 Jun 2012
Changing the standard treatment for lymphoma with bendamustine
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Changing the standard treatment for lymphoma with bendamustine ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012
Continuing bevacizumab with second-line chemotherapy for colorectal cancer
Dr Dirk Arnold - University Cancer Center Hamburg, Germany
Continuing bevacizumab with second-line chemotherapy for colorectal cancer ( Dr Dirk Arnold - University Cancer Center Hamburg, Germany )
3 Jun 2012
Combined chemo-radiation extends survival in patients with anaplastic...
Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam...
Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours ( Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands )
3 Jun 2012
Bendamustine regimen more effective for lymphoma than standard CHOP
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Bendamustine regimen more effective for lymphoma than standard CHOP ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012
Current treatment practices in metastatic castration resistant prostate cancer
Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo...
Current treatment practices in metastatic castration resistant prostate cancer ( Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo Berruti )
22 May 2012
Targeting DNA damage response and repair excluding PARP for triple negative...
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
17 May 2012
Molecular characterisation of breast cancer: the mutational landscape
Prof Sam Aparicio - University of British Columbia, Vancouver, Canada
Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )
17 May 2012
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer
Prof Richard Finn - Universtity of California, Los Angeles, USA
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer ( Prof Richard Finn - Universtity of California, Los Angeles, USA )
17 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation